Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18826063 | Joint Implants With Bone Interface Connectors | September 2024 | January 2025 | Allow | 5 | 0 | 1 | Yes | No |
| 18645617 | MULTICOMPONENT ARTICULAR SURFACE IMPLANT | April 2024 | December 2024 | Allow | 7 | 0 | 0 | No | No |
| 18634703 | DEVICE AND METHOD WITH REDUCED PACEMAKER RATE IN HEART VALVE REPLACEMENT | April 2024 | April 2025 | Allow | 12 | 2 | 0 | Yes | No |
| 18630351 | JOINT IMPLANT WITH CONSTANT AND CONTINUOUS RELEASE OF THERAPEUTIC AGENT | April 2024 | June 2025 | Abandon | 14 | 1 | 0 | No | No |
| 18608361 | INTRAOCULAR LENS HAVING CLOSED-LOOP HAPTIC STRUCTURES | March 2024 | April 2025 | Abandon | 13 | 1 | 0 | No | No |
| 18587687 | INTRAOCULAR LENSES HAVING ZONE-BY-ZONE STEP HEIGHT CONTROL | February 2024 | December 2024 | Allow | 9 | 0 | 0 | Yes | No |
| 18587766 | SUSPENDED SLEEVE ASSEMBLY COMPRISING A COMPRESSION SLEEVE AND A SUSPENSION STAND | February 2024 | April 2025 | Abandon | 14 | 1 | 0 | No | No |
| 18436900 | Bioactive Soft Tissue Implant And Methods Of Manufacture And Use Thereof | February 2024 | July 2024 | Allow | 5 | 0 | 1 | Yes | No |
| 18407726 | OPHTHALMIC LENSES HAVING AN EXTENDED DEPTH OF FOCUS FOR IMPROVING INTERMEDIATE VISION | January 2024 | April 2025 | Allow | 16 | 1 | 0 | No | No |
| 18393551 | OPHTHALMIC DEVICES, SYSTEM AND METHODS THAT IMPROVE PERIPHERAL VISION | December 2023 | January 2025 | Allow | 13 | 0 | 1 | Yes | No |
| 18389701 | MULTI-REGION REFRACTIVE LENSES FOR VISION TREATMENT | December 2023 | December 2024 | Allow | 11 | 0 | 1 | Yes | No |
| 18544133 | ACHROMATIC LENSES AND LENSES HAVING DIFFRACTIVE PROFILES WITH IRREGULAR WIDTH FOR VISION TREATMENT | December 2023 | June 2025 | Allow | 18 | 1 | 0 | Yes | No |
| 18542499 | ACHROMATIC LENSES WITH ZONE ORDER MIXING FOR VISION TREATMENT | December 2023 | November 2024 | Allow | 11 | 0 | 1 | Yes | No |
| 18534691 | PARTITION DESIGN AND MOLDING METHOD FOR ACETABULAR CUP PROSTHESIS WITH POROUS SURFACE | December 2023 | June 2024 | Allow | 6 | 0 | 0 | Yes | No |
| 18521847 | ACETABULAR RECONSTRUCTION PROSTHESIS WITH PILING-CUP SYSTEM | November 2023 | March 2024 | Allow | 3 | 0 | 0 | Yes | No |
| 18519178 | GLENOID IMPLANT ANCHOR POST | November 2023 | August 2024 | Allow | 9 | 0 | 0 | Yes | No |
| 18514281 | Fixation Devices And Prostheses For Soft Tissue Connection To The Same | November 2023 | May 2025 | Allow | 18 | 1 | 1 | Yes | No |
| 18504635 | SYSTEMS, METHODS, AND DEVICES FOR LATERAL AND POSTERIOR SACROILIAC JOINT FUSION | November 2023 | January 2025 | Allow | 14 | 2 | 1 | Yes | No |
| 18504370 | Lenticules for Intrastromal Corneal Implantation | November 2023 | February 2025 | Allow | 15 | 2 | 0 | No | No |
| 18491736 | INTRAOCULAR LENSES THAT IMPROVE PERIPHERAL VISION | October 2023 | September 2024 | Allow | 11 | 0 | 0 | Yes | No |
| 18489891 | SYSTEMS AND METHODS FOR KNEE ARTHROPLASTY | October 2023 | June 2024 | Allow | 8 | 0 | 0 | Yes | No |
| 18485546 | INTRAOCULAR DRUG DELIVERY PLATFORM | October 2023 | July 2024 | Allow | 10 | 0 | 0 | Yes | No |
| 18370945 | Femoral Component For Bone Conservation | September 2023 | January 2025 | Allow | 16 | 1 | 1 | Yes | No |
| 18470936 | INTRAOCULAR PSEUDOPHAKIC CONTACT LENS (IOPCL)-BASED TELESCOPIC APPROACH FOR TREATING AGE-RELATED MACULAR DEGENERATION (AMD) OR OTHER EYE DISORDERS | September 2023 | December 2024 | Allow | 14 | 1 | 0 | No | No |
| 18455371 | STABLE IOL BASE DESIGN TO SUPPORT SECOND OPTIC | August 2023 | September 2024 | Allow | 13 | 0 | 0 | Yes | No |
| 18452633 | Devices for Reconstruction of a Lens Capsule after Cataract Surgery | August 2023 | April 2025 | Allow | 20 | 0 | 1 | No | No |
| 18366376 | METHOD AND DEVICE FOR TREATING EYE DISEASE | August 2023 | January 2025 | Allow | 17 | 0 | 1 | Yes | No |
| 18230908 | IMPLANT AND IMPLANT SYSTEM | August 2023 | June 2024 | Allow | 10 | 0 | 0 | Yes | No |
| 18359744 | STAPHYLOMA SUPPORTING DEVICE AND METHOD FOR MODIFYING THE AXIAL LENGTH AND CURVATURE OF AN EYE | July 2023 | May 2024 | Allow | 10 | 0 | 0 | No | No |
| 18357441 | FULL DEPTH OF FOCUS INTRAOCULAR LENS | July 2023 | November 2024 | Allow | 16 | 1 | 0 | Yes | No |
| 18349805 | METHODS FOR LESS INVASIVE GLENOID REPLACEMENT | July 2023 | May 2024 | Allow | 10 | 0 | 0 | Yes | No |
| 18339150 | SACROILIAC JOINT STABILIZATION SYSTEM | June 2023 | November 2024 | Allow | 17 | 3 | 1 | Yes | No |
| 18325280 | IN-SITU ADJUSTABLE INTRAOCULAR LENS | May 2023 | August 2024 | Allow | 15 | 0 | 1 | Yes | No |
| 18324951 | SYNTHETIC HYDROGEL COMPOSITE | May 2023 | April 2024 | Allow | 11 | 0 | 0 | Yes | No |
| 18322489 | PROSTHETIC CAPSULAR DEVICES, SYSTEMS, AND METHODS | May 2023 | April 2024 | Allow | 11 | 0 | 0 | Yes | No |
| 18321083 | HARD-TISSUE IMPLANT COMPRISING A BULK IMPLANT, A FACE, PILLARS, SLOTS, AND AT LEAST ONE SUPPORT MEMBER | May 2023 | April 2024 | Allow | 11 | 0 | 0 | Yes | No |
| 18141636 | WRIST ARTHROPLASTY SYSTEM AND METHOD | May 2023 | December 2024 | Allow | 20 | 0 | 0 | No | No |
| 18307147 | ELECTROWETTING OPHTHALMIC DEVICES INCLUDING AN ELASTIC ELECTRODE | April 2023 | August 2024 | Allow | 15 | 1 | 0 | Yes | No |
| 18306347 | HEAT TUNABLE INTRAOCULAR LENS | April 2023 | May 2025 | Allow | 25 | 2 | 1 | No | No |
| 18302298 | ADJUSTABLE INTRAOCULAR LENSES AND METHODS OF POST-OPERATIVELY ADJUSTING INTRAOCULAR LENSES | April 2023 | August 2024 | Allow | 16 | 0 | 1 | Yes | No |
| 18298595 | MODULAR KNEE AUGMENT CONES | April 2023 | April 2024 | Allow | 12 | 0 | 0 | Yes | No |
| 18295912 | INTRAOCULAR LENS INSERTION DEVICE | April 2023 | November 2023 | Allow | 7 | 0 | 2 | Yes | No |
| 18127078 | ADJUSTABLE TIBIAL TRIAL INSTRUMENT AND ORTHOPAEDIC SURGICAL METHOD OF USING THE SAME | March 2023 | March 2024 | Allow | 12 | 0 | 0 | Yes | No |
| 18126301 | PERCUTANEOUS HEART VALVE PROSTHESIS | March 2023 | March 2024 | Allow | 12 | 0 | 0 | Yes | No |
| 18124425 | INTRAOCULAR LENS | March 2023 | February 2024 | Allow | 11 | 0 | 1 | Yes | No |
| 18186826 | PROSTHETIC CAPSULAR DEVICES, SYSTEMS, AND METHODS | March 2023 | March 2024 | Allow | 11 | 0 | 0 | Yes | No |
| 18171343 | ACHROMATIC LENSES FOR VISION TREATMENT | February 2023 | June 2024 | Allow | 16 | 0 | 1 | Yes | No |
| 18106708 | BONE IMPLANT HOLDING AND SHAPING TRAY | February 2023 | March 2024 | Allow | 14 | 0 | 0 | Yes | No |
| 18095981 | SACROILIAC JOINT STABILIZATION SYSTEM | January 2023 | July 2023 | Allow | 6 | 0 | 1 | Yes | No |
| 18067284 | INTRAOCULAR LENS HAVING INPUT AND OUTPUT ELECTRONICS | December 2022 | February 2024 | Allow | 14 | 0 | 0 | Yes | No |
| 18066872 | THREADED IMPLANTS AND METHODS OF USE ACROSS BONE SEGMENTS | December 2022 | June 2025 | Allow | 30 | 2 | 0 | Yes | No |
| 18064235 | INTRAOCULAR LENS THAT IMPROVES OVERALL VISION WHERE THERE IS A LOCAL LOSS OF RETINAL FUNCTION | December 2022 | April 2025 | Allow | 28 | 3 | 0 | Yes | No |
| 18072445 | HYBRID ACCOMODATING INTRA-OCULAR LENS AND METHOD OF USE THEREOF | November 2022 | June 2025 | Allow | 31 | 1 | 0 | No | No |
| 18070737 | SYSTEMS AND METHODS FOR PREPARING CORNEAL TISSUE FOR IMPLANT | November 2022 | February 2024 | Allow | 14 | 0 | 0 | Yes | No |
| 18058150 | METHODS FOR LESS INVASIVE GLENOID REPLACEMENT | November 2022 | February 2023 | Allow | 2 | 0 | 0 | Yes | No |
| 17989763 | ARTIFICIAL DISK WITH SENSORS | November 2022 | January 2025 | Allow | 26 | 2 | 0 | Yes | No |
| 17987047 | REPAIR OF SHOULDER-JOINT LESIONS | November 2022 | February 2023 | Allow | 3 | 0 | 1 | Yes | No |
| 18052853 | DIFFRACTIVE INTRAOCULAR LENSES FOR EXTENDED RANGE OF VISION | November 2022 | March 2025 | Allow | 29 | 1 | 1 | No | No |
| 17975872 | CORNEAL IMPLANT | October 2022 | January 2024 | Allow | 15 | 0 | 0 | Yes | No |
| 17975851 | CORNEAL IMPLANT | October 2022 | August 2024 | Allow | 22 | 2 | 0 | No | No |
| 17973964 | IMPLANT FOR REMOVABLE PROSTHETIC NAIL | October 2022 | February 2024 | Allow | 15 | 0 | 0 | Yes | No |
| 17966663 | PERCUTANEOUS HEART VALVE PROSTHESIS | October 2022 | February 2023 | Allow | 4 | 1 | 0 | Yes | No |
| 18045622 | MINIMALLY INVASIVE AB INTERNO TRIPLE SURGERY FOR OPEN-ANGLE GLAUCOMA | October 2022 | August 2023 | Allow | 10 | 1 | 0 | Yes | No |
| 17937076 | OPHTHALMIC IMPLANTS FOR CORRECTING VISION WITH A TUNABLE OPTIC, AND METHODS OF MANUFACTURE AND USE | September 2022 | January 2025 | Allow | 28 | 0 | 1 | Yes | No |
| 17952672 | COMPOSITE JOINT IMPLANT | September 2022 | December 2024 | Abandon | 27 | 1 | 1 | No | No |
| 17943525 | ORTHOPAEDIC KNEE IMPLANT SYSTEM WITH CONTROLLED STIFFNESS | September 2022 | January 2024 | Allow | 16 | 0 | 0 | Yes | No |
| 17942892 | Meniscus Prosthetic Devices with Anti-Migration or Radiopaque Features | September 2022 | December 2023 | Allow | 15 | 0 | 0 | Yes | No |
| 17929473 | AUGMENTATION DEVICE, AUGMENTATION SYSTEM, AND IMPLANTATION METHOD | September 2022 | February 2025 | Allow | 30 | 1 | 1 | Yes | No |
| 17895585 | NON-PATIENT-SPECIFIC CRANIOFACIAL IMPLANTS FOR CORRECTING AND/OR PREVENTING TEMPORAL OR PTERIONAL DEFORMITIES | August 2022 | November 2023 | Allow | 15 | 0 | 0 | Yes | No |
| 17878196 | METHODS AND APPARATUSES FOR ATTACHMENT OF POROUS COATINGS TO IMPLANTS AND PRODUCTS THEREOF | August 2022 | December 2023 | Allow | 16 | 0 | 0 | Yes | No |
| 17759249 | STAPHYLOMA SUPPORTING DEVICE AND METHOD FOR MODIFYING THE AXIAL LENGTH AND CURVATURE OF AN EYE | July 2022 | April 2023 | Allow | 9 | 0 | 1 | Yes | No |
| 17868127 | PASSIVELY-COUPLED EYE IMPLANT | July 2022 | July 2024 | Allow | 24 | 0 | 0 | Yes | No |
| 17851373 | ORTHOPAEDIC KNEE PROSTHESIS HAVING CONTROLLED CONDYLAR CURVATURE | June 2022 | January 2024 | Allow | 18 | 0 | 0 | Yes | No |
| 17849031 | BONE GRAFT SYSTEM | June 2022 | June 2024 | Allow | 23 | 0 | 0 | Yes | No |
| 17845881 | SYNTHETIC HYDROGEL COMPOSITE | June 2022 | December 2022 | Allow | 6 | 0 | 1 | Yes | No |
| 17807548 | PROTECTIVE LENS HOLDER | June 2022 | January 2024 | Allow | 19 | 1 | 0 | Yes | No |
| 17839407 | EXCHANGEABLE OPTICS AND THERAPEUTICS | June 2022 | January 2024 | Allow | 19 | 0 | 0 | Yes | No |
| 17784049 | EYE IMPLANT FOR AN ACCOMMODATIVE INTRAOCULAR LENS | June 2022 | April 2023 | Allow | 10 | 0 | 2 | Yes | No |
| 17829726 | INTRAOCULAR LENSES WITH SHAPE-CHANGING OPTICS AND STABILIZING PROPERTIES | June 2022 | December 2022 | Allow | 6 | 1 | 0 | Yes | No |
| 17804120 | OPHTHALMIC LENSES FOR BALANCING COMA ABERRATIONS | May 2022 | May 2024 | Allow | 23 | 0 | 0 | Yes | No |
| 17752352 | ORTHOPAEDIC FEMORAL COMPONENT HAVING CONTROLLED CONDYLAR CURVATURE | May 2022 | June 2024 | Allow | 25 | 1 | 0 | Yes | No |
| 17751555 | INTRAOCULAR PSEUDOPHAKIC CONTACT LENS WITH MECHANISM FOR SECURING BY ANTERIOR LEAFLET OF CAPSULAR WALL AND RELATED SYSTEM AND METHOD | May 2022 | June 2025 | Allow | 37 | 0 | 0 | Yes | No |
| 17750774 | LATERALIZED DUAL-MOBILITY ASSEMBLY | May 2022 | November 2023 | Allow | 17 | 0 | 0 | Yes | No |
| 17663748 | INTRAOCULAR LENSES HAVING ZONE-BY-ZONE STEP HEIGHT CONTROL | May 2022 | November 2023 | Allow | 18 | 0 | 0 | Yes | No |
| 17662599 | INTRAOCULAR IMPLANT WITH REMOVABLE OPTIC | May 2022 | May 2024 | Abandon | 24 | 1 | 0 | No | No |
| 17739715 | PROSTHETIC STEM FOR A PROSTHETIC IMPLANT | May 2022 | January 2024 | Allow | 20 | 0 | 1 | Yes | No |
| 17773743 | TIBIAL PROSTHESIS AND KNEE PROSTHESIS | May 2022 | April 2025 | Allow | 36 | 0 | 0 | No | No |
| 17728773 | SUSPENDED SLEEVE ASSEMBLY COMPRISING A COMPRESSION SLEEVE AND A SUSPENSION STAND | April 2022 | October 2023 | Allow | 18 | 0 | 0 | Yes | No |
| 17725046 | Bioactive Soft Tissue Implant And Methods Of Manufacture And Use Thereof | April 2022 | August 2024 | Allow | 28 | 0 | 1 | Yes | No |
| 17659588 | GLENOID IMPLANT ANCHOR POST | April 2022 | September 2023 | Allow | 17 | 0 | 0 | Yes | No |
| 17657522 | SYSTEMS AND METHODS FOR CONTROLLED FACET REPOSITIONING IN THE CALCANEUS | March 2022 | June 2025 | Allow | 39 | 0 | 1 | Yes | No |
| 17707188 | Cartilage Measurement Device and Method of Use | March 2022 | October 2023 | Allow | 19 | 0 | 1 | Yes | No |
| 17763923 | INTERSPINOUS STABILIZATION DEVICE | March 2022 | December 2024 | Allow | 32 | 2 | 0 | Yes | No |
| 17761751 | ENDOPROSTHESIS AND A METHOD OF PRODUCING AN ENDOPROSTHESIS | March 2022 | May 2025 | Allow | 38 | 0 | 1 | Yes | No |
| 17761441 | INTRAOCULAR LENS | March 2022 | January 2025 | Abandon | 34 | 0 | 1 | No | No |
| 17693283 | Dome Toe Resurfacing System | March 2022 | May 2023 | Allow | 14 | 0 | 0 | Yes | No |
| 17640214 | MEMBRANE BODY FOR TUBULAR TREATMENT DEVICE AND TUBULAR TREATMENT DEVICE | March 2022 | March 2025 | Allow | 36 | 1 | 0 | Yes | No |
| 17677579 | LINER FOR PROSTHETIC AND ORTHOPEDIC SYSTEMS | February 2022 | December 2023 | Allow | 22 | 0 | 1 | Yes | No |
| 17650192 | PROSTHETIC CAPSULAR DEVICES, SYSTEMS, AND METHODS | February 2022 | May 2023 | Allow | 15 | 0 | 0 | Yes | No |
| 17587422 | INTRAOCULAR LENS INCLUDING SILICONE OIL | January 2022 | May 2022 | Allow | 4 | 1 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BLANCO, JAVIER G.
With a 29.4% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 17.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner BLANCO, JAVIER G works in Art Unit 3774 and has examined 1,087 patent applications in our dataset. With an allowance rate of 81.3%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 26 months.
Examiner BLANCO, JAVIER G's allowance rate of 81.3% places them in the 46% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by BLANCO, JAVIER G receive 1.27 office actions before reaching final disposition. This places the examiner in the 24% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by BLANCO, JAVIER G is 26 months. This places the examiner in the 64% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.
Conducting an examiner interview provides a +59.4% benefit to allowance rate for applications examined by BLANCO, JAVIER G. This interview benefit is in the 97% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 29.8% of applications are subsequently allowed. This success rate is in the 49% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 14.2% of cases where such amendments are filed. This entry rate is in the 9% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 20% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 60.5% of appeals filed. This is in the 32% percentile among all examiners. Of these withdrawals, 38.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 40.9% are granted (fully or in part). This grant rate is in the 41% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 9.5% of allowed cases (in the 95% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.2% of allowed cases (in the 45% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.